Alison Hall

Senior Advisor (Humanities)

Alison supports the work of PHG Foundation’s regulation and ethics team as a Senior Advisor (Humanities). She focuses on data and device regulation that impacts innovations in healthcare. This includes appraising the impact of regulatory changes to UK and EU data protection and medical devices regulation for clinical genetics services and medical research; working with stakeholders and statutory authorities to facilitate optimal data sharing policies in the NHS; and assessing how in vitro diagnostic devices regulation impacts on IVD device and software development, including the development and implementation of polygenic risk scores. Alison is also a member of various national ethics and data access committees.

Reports

Policy briefings

Consultation responses

The right to privacy: digital data

Discussion papers

Blogs

News

Comment to STC Genomics and Genome Editing Inquiry

Journal papers

Applying GDPR roles and responsibilities to scientific data sharing
Regina Becker, Adrian Thorogood, Jasper Bovenberg, Colin Mitchell, Alison Hall, International Data Privacy Law, Volume 12, Issue 3, August 2022, Pages 207–219
How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests?
Moorthie S, Hall A, Babb de Villiers C, Janus J, Brigden T, Blackburn L, Kroese M. Future Medicine. 15 March 2022.
Genetic database software as medical devices
Thorogood A, Touré S.B, Ordish J, Hall A, Knoppers B.
Human Mutation. 2018; Vol. 39 Iss.11. pp1702-1712.
A response to the forensic genetics policy initiative’s report “Establishing Best Practice for Forensic DNA Databases”
Samuel, G, Howard H.C, Cornel M, van El C, Hall A, Forzano F, Prainsack B.
Forensic Science International. 2018 5 July; Genetics (online).
R isk stratification, genomic data and the law
Hall A, Finnegan T, Susmita C et al.
J Community Genet. 2018;9:195.
Better governance, better access: practising responsible data sharing in the METADAC governance infrastructure.
Murtagh M, B Mwenza, A Hall et al.
Hum Genomics. 2018;12:24
Risk stratification, genomic data and the law.
Hall A, Finnegan T, Chowdhury S, Dent T, Kroese M, Burton H.
J Community Genet. 2018; https://doi.org/10.1007/s12687-018-0358-4. [Epub ahead of print]
Genomic medicine and data sharing
Raza S, Hall A.
Br Med Bull. 2017 Sep; 1;123(1):35-45.
Exploring the potential duty of care in clinical genomics under UK law
Mitchell C, Ploem C, Chico V, Ormondroyd E, Hall A, Wallace S, Fay M, Goodwin D, Bell J, Phillips S, Taylor J.C, Hennekam R, Kaye J.
Medical Law International. 2017 Aug 14 [Epub ahead of print]
What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?
Chowdhury S, Hall A, Pashayan N, Pharoah P.
Journal of Medical Ethics. 2013 Mar 1 [Epub ahead of print] PubMed PMID: 23454719
Ethical issues and best practice in clinically based genomic research: Exeter Stakeholders Meeting Report
Bewshea C, Carrieri D, Hall A, Walker G.
J Med Ethics doi:10.1136/medethics-2016-103530
Responsible implementation of expanded carrier screening
Henneman L, Borry P, Hall A.
Eur J Hum Genet. 2016 Jun; 24(6)w1-e12.
Known unknowns: building an ethics of uncertainty into genomic medicine
Gaff C, Hall A, Leonard S, Newson A.
BMC Medical Genomics (2016) 9:57 DOI 10.1186/s12920-016-0219-0
Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening
de Wert G, Dondorp W, Hall A.
European Journal of Human Genetics. 2015 March 18.
Considerations in establishing a post-mortem brain and tissue bank for the study of myalgic encephalomyelitis/chronic fatigue syndrome: a proposed protocol
Bowman E, Goldring K, Gveric D, Hall A, Lacerda E, Nacul L, O'Donovan D, Pheby D.
BMC Research Notes. 2014; (7):370.
Personalized medicine: what's in a name?
Burton H, Hall A, Kroese M, Pokorska-Bocci A, Sagoo G, Stewart A.
Personalised Medicine. 2014; 11(2):197-210.
Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues
Alberg C, Hall A, Hallowell N, Zimmern R.
Journal of Medical Ethics. Epub 2014 Jul 18.
A Toolkit to assess health needs for congenital disorders in low- and middle-income countries: an instrument for public health action
Nacul L,Stewart A, Alberg C, Chowdhury S, Burton H, Darlison MW, Grollman C, Hall A, Modell B, Moorthie S, Sagoo G, .
Journal of Public Health. 2014 June; 36(2):243-50. doi: 10.1093/pubmed/fdt048 : May 10, 2013 [Epub ahead of print]
Personalised medicine in the UK: challenges of implementation and impact on healthcare system
Burton H, Hall A, Kroese M, Pokorska-Bocci A, Sagoo G.
Genome Medicine. 2014 Apr 25; 6(4):28.
What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?
Burton H, Chowdhury S, Hall A, Pashayan N, Pharoah P.
Journal of Medical Ethics. 2014 Mar; 40(3):163-7.
Public health genomics and personalised prevention: lessons from the COGS project
Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
Journal of Internal Medicine. 2013 Nov; 274(5):451-6
Life insurance: genomic stratification and risk classification
Burton H, Chowdhury S, Dent T, Feze I, Foulkes W, Hall A, Hamet P, Joly Y, Kirwan N, Knoppers B, Macdonald A, Pashayan N, Simard J, Van Hoyweghen I.
European Journal of Human Genetics. 2013 Oct 16. doi: 10.1038/ejhg.2013.228
Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues
Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
Journal of Public Health (Oxf). 2013 Aug 28.
Public health implications from COGS and potential for risk stratification and screening
Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
Nature Genetics. 2013 Apr; 45(4):349-51 doi: 10.1038/ng.2582. PubMed PMID: 23535723
Informatics and clinical genome sequencing: opening the black box
Moorthie S, Hall A, Wright C.
Genet Medicine. 2013 Mar; 15(3):165-71.
Incorporating genomics into breast and prostate cancer screening: assessing the implications
Burton H, Chowdhury S, Dent T, Hall A, Hall P, Lyratzopoulos G, Pashayan N, Pharoah P.
Genetics in Medicine. 2013 Feb 14 doi: 10.1038/gim.2012.167. [Epub ahead of print] PubMed PMID: 23412607.
Stratified cancer screening: the practicalities of implementation.
Burton H, Chowdhury S, Dent T, Eccles D, Eeles R, Hall A, Jbilou J, Lyratzopoulos G, Pashayan N, Pharoah P, Rafi I, Segnan N, T.
Public Health Genomics. 2013;16(3):94-9.
Legal and ethical implications of inherited cardiac disease in clinical practice within the UK
Burton H, Hall A.
Journal of Medical Ethics. 2010; 36: 762-766.
Extending the reach of public health genomics: What should be the agenda for public health in an era of genome-based and "personalized" medicine?
Burke W, Hall A, Karmali M, Khoury M, Knoppers B, Meslin E, Stanley F, Wright C, Zimmern R.
Genetics in Medicine. 2010 Nov; Vol 15.
Regulating direct-to-consumer genetic tests: What is all the fuss about?
Hall A, Wright C, Zimmern R.
Genetics in Medicine. 2010 Oct 1 [Epub ahead of print]
Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications
Bostanci A, Hall A, Wright C.
Public Health Genomics. 2010; 13(4):246-55. Epub 2010 Apr 15.
Inherited cardiovascular conditions: the challenges of genomic medicine
Alberg C, Burton H, Hall A, Inherited Cardiovascular Conditions Services , Sagoo G, Stewart A.
Heart. 2010 Mar; 96(6):474-6
Biomarkers, Dementia, and Public Health
Brayne C, Hall A, Matthews F, Wright C.
Annals of the New York Academy of Sciences. 2009; 118:11-19.
Beyond Bristol and Alder Hey: The Future Regulation of Human Tissue
Hall A, Liddell K.
Medical Law Review. 2005; Summer:170-223

Alison Hall

Genomics and policy newsletter